Peritoneal Neoplasms
"Peritoneal Neoplasms" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Tumors or cancer of the PERITONEUM.
Descriptor ID |
D010534
|
MeSH Number(s) |
C04.588.033.513 C04.588.274.780 C06.301.780 C06.844.620
|
Concept/Terms |
Peritoneal Surface Malignancy- Peritoneal Surface Malignancy
- Malignancy, Peritoneal Surface
- Peritoneal Surface Malignancies
- Surface Malignancy, Peritoneal
- Peritoneal Carcinomatosis
- Carcinomatosis, Peritoneal
- Peritoneal Carcinomatoses
|
Below are MeSH descriptors whose meaning is more general than "Peritoneal Neoplasms".
Below are MeSH descriptors whose meaning is more specific than "Peritoneal Neoplasms".
This graph shows the total number of publications written about "Peritoneal Neoplasms" by people in this website by year, and whether "Peritoneal Neoplasms" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
Year | Major Topic | Minor Topic | Total |
---|
2000 | 1 | 0 | 1 | 2001 | 1 | 0 | 1 | 2004 | 2 | 0 | 2 | 2005 | 2 | 1 | 3 | 2007 | 1 | 0 | 1 | 2008 | 2 | 1 | 3 | 2009 | 1 | 0 | 1 | 2010 | 5 | 1 | 6 | 2011 | 2 | 0 | 2 | 2012 | 2 | 0 | 2 | 2013 | 5 | 0 | 5 | 2014 | 4 | 2 | 6 | 2015 | 1 | 1 | 2 | 2016 | 6 | 0 | 6 | 2017 | 2 | 0 | 2 | 2018 | 2 | 0 | 2 | 2019 | 4 | 0 | 4 | 2020 | 1 | 0 | 1 | 2022 | 4 | 0 | 4 | 2024 | 3 | 0 | 3 |
To return to the timeline, click here.
Below are the most recent publications written about "Peritoneal Neoplasms" by people in Profiles.
-
Liu J, Berchuck A, Backes FJ, Cohen J, Grisham R, Leath CA, Martin L, Matei D, Miller DS, Robertson S, Barroilhet L, Uppal S, Hendrickson AW, Gershenson DM, Gray HJ, Hakam A, Jain A, Konecny GE, Moroney J, Ratner E, Schorge J, Thaker PH, Werner TL, Zsiros E, Behbakht K, Chen LM, DeRosa M, Eisenhauer EL, Leiserowitz G, Litkouhi B, McHale M, Percac-Lima S, Rodabaugh K, Vargas R, Jones F, Kovach E, Hang L, Ramakrishnan S, Alvarez RD, Armstrong DK. NCCN Guidelines? Insights: Ovarian Cancer/Fallopian Tube Cancer/Primary Peritoneal Cancer, Version 3.2024. J Natl Compr Canc Netw. 2024 10; 22(8):512-519.
-
Khomiak A, Ghaffar S, Rodriguez Franco S, Ziogas IA, Yee EJ, Franklin O, Cumbler E, Chauhan A, McCarter MD, Gleisner AL, Ahrendt S, Del Chiaro M, Schulick RD, Mungo B. Survival Outcomes of Cytoreductive Surgery with HIPEC in Gastric Adenocarcinoma: A National Cancer Database Study. Ann Surg Oncol. 2024 Dec; 31(13):8549-8559.
-
Wach MM, Nunns G, Hamed A, Derby J, Jelinek M, Tatsuoka C, Holtzman MP, Zureikat AH, Bartlett DL, Ahrendt SA, Pingpank JF, Choudry MHA, Ongchin M. Normal CEA Levels After Neoadjuvant Chemotherapy and Cytoreduction with Hyperthermic Intraperitoneal Chemoperfusion Predict Improved Survival from Colorectal Peritoneal Metastases. Ann Surg Oncol. 2024 Apr; 31(4):2391-2400.
-
Rouhi AD, Choudhury RA, Hoeltzel GD, Yule A, Williams NN, Dumon KR, Karakousis GC. Delayed CRS-HIPEC Is Associated with Decreased Survival in Patients with Malignant Peritoneal Mesothelioma: A Markov Decision Analysis. J Gastrointest Surg. 2023 05; 27(5):995-997.
-
Armstrong DK, Alvarez RD, Backes FJ, Bakkum-Gamez JN, Barroilhet L, Behbakht K, Berchuck A, Chen LM, Chitiyo VC, Cristea M, DeRosa M, Eisenhauer EL, Gershenson DM, Gray HJ, Grisham R, Hakam A, Jain A, Karam A, Konecny GE, Leath CA, Leiserowitz G, Liu J, Martin L, Matei D, McHale M, McLean K, Miller DS, Percac-Lima S, Remmenga SW, Schorge J, Stewart D, Thaker PH, Vargas R, Hendrickson AW, Werner TL, Zsiros E, Dwyer MA, Hang L. NCCN Guidelines? Insights: Ovarian Cancer, Version 3.2022. J Natl Compr Canc Netw. 2022 09; 20(9):972-980.
-
Nepal S, Schwertner A, Cunningham JM. Mucinous ascites: Pseudomyxoma peritonei. Cleve Clin J Med. 2022 09 01; 89(9):491-493.
-
Goldenthal SB, Reimers MA, Singhal U, Farha M, Mehra R, Piert M, Tosoian JJ, Modi PK, Curci N, Peabody J, Kleer E, Smith DC, Morgan TM. Prostate Cancer With Peritoneal Carcinomatosis: A Robotic-assisted Radical Prostatectomy-based Case Series. Urology. 2022 09; 167:171-178.
-
Torphy RJ, Stewart C, Sharma P, Halpern AL, Oase K, Herter W, Bartsch C, Friedman C, Del Chiaro M, Schulick RD, Gleisner A, McCarter MD, Ahrendt SA. Dextrose-Containing Carrier Solution for Hyperthermic Intraperitoneal Chemotherapy: Increased Intraoperative Hyperglycemia and Postoperative Complications. Ann Surg Oncol. 2020 Dec; 27(13):4874-4882.
-
Moore KN, Miller A, Bell-McGuinn KM, Schilder RJ, Walker JL, O'Cearbhaill RE, Guntupalli SR, Armstrong DK, Hagemann AR, Gray HJ, Duska LR, Mathews CA, Chen A, O'Malley D, Gordon S, Fracasso PM, Aghajanian C. A phase I study of intravenous or intraperitoneal platinum based chemotherapy in combination with veliparib and bevacizumab in newly diagnosed ovarian, primary peritoneal and fallopian tube cancer. Gynecol Oncol. 2020 01; 156(1):13-22.
-
O'Cearbhaill RE, Deng W, Chen LM, Lucci JA, Behbakht K, Spirtos NM, Muller CY, Benigno BB, Powell MA, Berry E, Tewari KS, Hanjani P, Lankes HA, Aghajanian C, Sabbatini PJ. A phase II randomized, double-blind trial of a polyvalent Vaccine-KLH conjugate (NSC 748933 IND# 14384)?+ OPT-821 versus OPT-821 in patients with epithelial ovarian, fallopian tube, or peritoneal cancer who are in second or third complete remission: An NRG Oncology/GOG study. Gynecol Oncol. 2019 12; 155(3):393-399.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|